Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis

Area of Science:

• Immunogenetics
• Cardiovascular Disease Research
• Molecular Biology

Background:

• Atherosclerosis pathogenesis is debated, with microbial involvement via Toll-like receptors (TLRs) being a recent hypothesis.
• Polymorphisms in TLR-2 and TLR-4 are linked to cardiovascular risks.
• Intracellular pathogens like C. pneumoniae and CMV may activate TLR-9 signaling.

Purpose of the Study:

• To investigate the correlation between two common promoter polymorphisms of the TLR-9 gene and atherogenesis.
• To determine if TLR-9 gene variations influence the risk of developing atherosclerosis or restenosis.

Main Methods:

• Real-Time PCR was used to analyze T-1237C and T-1486C polymorphisms in TLR-9.
• Studies included patients undergoing angioplasty and healthy controls.
• Restenosis was defined as >50% luminal diameter reduction on follow-up angiography.

Main Results:

• The analyzed TLR-9 polymorphisms can create new transcription factor binding sites.
• No statistically significant association was detected between TLR-9 polymorphisms and atherogenesis.
• No correlation was found between TLR-9 polymorphisms and restenosis after angioplasty.

Conclusions:

• The studied TLR-9 promoter polymorphisms are not implicated in the development of atherosclerosis.
• These specific genetic variations of TLR-9 do not appear to be risk factors for restenosis.